So the average number of patients per pharmacy is around 1 per day per pharmacy using Medadvisor. That does not sounds like significant value creation for a pharmacy given how many scripts they are processing over the counter a day!? I presume that this stat is also not "active" users either so could be a lot less. I am having real trouble seeing evidence of successful adoption and growth. The revenue growth is mostly from the acquisition right? What are the organic growth metrics? @futurenow , I'm just not sure the underlying metrics here are working?
Ann: MedAdvisor FY18 Annual Report & Appendix 4E, page-9
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
